Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
According to research conducted by PricewaterhouseCoopers (PwC), 45% of the economic gains by the end of this decade will be driven by the enhancement in AI technology that will provide impetus to consumer...
DALLAS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its...
15.11.2022 - Press release Cambridge, MA U.S.A. (November 15, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP companion diagnostics ...
Global Pancreatic Cancer Treatment Market is valued at USD 2.61 Billion in 2021, and it is anticipated to attain a value of USD 3.78 Billion by 2028, at a...
14.09.2022 - Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ('A.I.') and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery ... Seite 1